As executive director for evaluation and research, Elaine Wang leads an experienced team of quantitative and qualitative faculty and researchers to design, implement, monitor, and evaluate programs and policies using customized analytic solutions for various governmental and non-governmental agencies.
Dr. Wang is a mix-methods health services and health policy researcher with nearly 20 years of professional experience. She applies her interest and expertise in cost, coverage, and access issues as they impact vulnerable populations and leads Medicaid 1115 waiver evaluation initiatives in Massachusetts and other states. She has experience in value-based purchasing programs and has led various projects for the Centers for Medicare & Medicaid Services, including leading a Medicare Part D star rating project, developing performance measures for monitoring Medicare Parts C and D plans, and helping create a Qualified Health Plan Quality Rating system.
In addition, her work relates to the behavioral health needs of children and families. This includes evaluating a home-based pediatric palliative care model, a demonstration of community-based alternative to psychiatric residential treatment facilities for children with serious emotional disturbance, and a psychiatric consultation model for providers treating children with autism or intellectual disability.
Before joining Commonwealth Medicine, Wang held leadership roles at policy consulting firms, including the American Institutes for Research and IMPAQ International. Previously, she worked at the University of Maryland Baltimore and the Center on Budget and Policy Priorities, and helped lead projects at the Agency for Healthcare Research and Quality and the Patient-centered Outcome Research Institute.
Wang earned a bachelor’s degree and master's degree in public administration from Nanjing University, and a master's degree and a doctorate in public policy with a focus on program evaluation from the University of Maryland.